Victory Capital Management
AMED

Victory Capital Management’s Amedisys AMED Stock Holding History

Victory Capital Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-18,652
Closed -$1.84M – 2418
2025
Q2 		$1.84M Buy
18,652
+12,783
+218% +$1.21M ﹤0.01% 1611
2025
Q1 		$544K Sell
5,869
-219
-4% -$20.2K ﹤0.01% 2007
2024
Q4 		$553K Sell
6,088
-182
-3% -$16.7K ﹤0.01% 2005
2024
Q3 		$605K Sell
6,270
-484
-7% -$47.2K ﹤0.01% 1960
2024
Q2 		$620K Sell
6,754
-25
-0.4% -$2.32K ﹤0.01% 1907
2024
Q1 		$625K Sell
6,779
-106
-2% -$9.93K ﹤0.01% 1917
2023
Q4 		$654K Sell
6,885
-954
-12% -$89.1K ﹤0.01% 1910
2023
Q3 		$732K Sell
7,839
-243
-3% -$22.5K ﹤0.01% 1818
2023
Q2 		$739K Buy
8,082
+446
+6% +$36.6K ﹤0.01% 1818
2023
Q1 		$562K Sell
7,636
-586
-7% -$50.7K ﹤0.01% 1958
2022
Q4 		$687K Sell
8,222
-19,227
-70% -$1.73M ﹤0.01% 1901
2022
Q3 		$2.66M Sell
27,449
-31,713
-54% -$3.78M ﹤0.01% 1383
2022
Q2 		$6.22M Sell
59,162
-24,247
-29% -$3.1M 0.01% 1199
2022
Q1 		$14M Buy
83,409
+41,192
+98% +$6.15M 0.01% 1005
2021
Q4 		$6.83M Buy
42,217
+1,100
+3% +$177K 0.01% 1246
2021
Q3 		$6.13M Sell
41,117
-8,415
-17% -$1.75M 0.01% 1268
2021
Q2 		$12.1M Buy
49,532
+5,392
+12% +$1.41M 0.01% 1066
2021
Q1 		$11.7M Sell
44,140
-19,907
-31% -$5.61M 0.01% 1097
2020
Q4 		$18.8M Sell
64,047
-18,366
-22% -$4.71M 0.02% 894
2020
Q3 		$19.5M Buy
82,413
+32,129
+64% +$7.3M 0.03% 812
2020
Q2 		$9.98M Sell
50,284
-171,518
-77% -$32M 0.01% 1012
2020
Q1 		$40.7M Buy
221,802
+100,981
+84% +$18M 0.03% 650
2019
Q4 		$20.2M Sell
120,821
-3,702
-3% -$551K 0.02% 821
2019
Q3 		$16.3M Buy
124,523
+120,946
+3,381% +$15.7M 0.02% 873
2019
Q2 		$434K Buy
3,577
+1,850
+107% +$220K ﹤0.01% 1375
2019
Q1 		$213K Buy
+1,727
New +$217K ﹤0.01% 1550
2018
Q1 		– Sell
-3,076
Closed -$162K – 1820
2017
Q4 		$162K Sell
3,076
-545,743
-99% -$28.8M ﹤0.01% 1621
2017
Q3 		$30.7M Sell
548,819
-153,420
-22% -$8.11M 0.07% 462
2017
Q2 		$44.1M Buy
702,239
+10,080
+1% +$587K 0.1% 327
2017
Q1 		$35.4M Buy
692,159
+144,044
+26% +$6.87M 0.08% 405
2016
Q4 		$23.4M Sell
548,115
-262,512
-32% -$11.2M 0.06% 528
2016
Q3 		$38.5M Buy
+810,627
New +$40.5M 0.11% 325

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $115M AUM 48.08% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Victory Capital Management's AMED Position: Q3 2025 in Review

Victory Capital Management sold out of Amedisys (AMED) in Q3 2025, closing a stake of 18,652 shares — an estimated $1.84M sold.

Victory Capital Management first reported a position in AMED in Q3 2016 and held it in 32 quarters. The position peaked at $44.1M in Q2 2017. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Victory Capital Management reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Victory Capital Management sold 18,652 Amedisys shares in Q3 2025, an estimated $1.84M.
  • Victory Capital Management first reported a position in Amedisys in Q3 2016 and held it in 32 quarters.
  • Victory Capital Management's Amedisys position peaked at $44.1M in Q2 2017.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Victory Capital Management's 13F filing for Q3 2025, filed 12 Nov 2025.